Scope International announces successful FDA inspection

Scope International AG is proud to announce that its subsidiary in the United States, Scope International USA, Inc., was successfully inspected by the US Food and Drug Administration in June 2019. The outcome of this FDA inspection is the most recent example of the high-quality results produced by the SCOPE team.  Our clients can focus

Spotlight on our Biostatistic experts and strategic consulting team

Scope International AG is pleased to announce the appointment of Björn Boße as new head of biostatistics. Together with Dr. Klaus Junge as Senior Biostatisticial Advisor Scope International offers an exceptional expertise in biostatistics. Björn and Klaus have both more than 20 years of experience in the pharmaceutical industry as e.g. Director Biostatistics and Executive

Adam Braithwaite appointed to the Business Development Team for the U.S.

Scope International AG is pleased to announce the appointment of Adam Braithwaite as the key contact for Business Development in the U.S. Adam will join the SCOPE BD team as part of its North American subsidiary, Scope International USA, based in Pittsburgh, PA. In his new position, he will support our clients for their ongoing

Andrew Bradshaw new UK Managing Director

Scope International AG has announced the appointment of Andrew Bradshaw as the new UK Managing Director for its subsidiary, based in Manchester, UK. Guiding a highly motivated and qualified team, Andrew will be responsible for the strategic development of Scope International (UK) Ltd.

New Managing Director for North American Operations

Scope International AG is pleased to announce the appointment of Amy O’Sullivan as the new Managing Director of its North American subsidiary, based in Pittsburgh, Pennsylvania. Guiding SCOPE’s business in our fastest growing market, Amy will take over an essential part of our strategic development and leading a growing team.